Key words : Glucagon-like peptide-1 Metabolic diseases Myostatin Obesity Sarcopenia GRAPHICAL ABSTRACT INTRODUCTION Metabolic syndrome is a cluster of conditions commonly associated with aging, such as insulin resistance and abdominal obesity, which can lead to complications including cardiovascular disease, hypertension, and type 2 diabetes.[1] This pathological condition is now considered an epidemic due to its rising global prevalence across all age groups, from children to adults.[2] A key challenge in managing metabolic syndrome is the absence of a single drug that can treat the disease due to its multifactorial nature.[3] As a result, most available medications for metabolic syndrome can only target one or more of its components but cannot fully eradicate the syndrome

Tryptophan oxidation is the most common degradation route detected by RP-HPLC in stored melanocortin analogues, with histidine a secondary site of concern, and freeze-thaw cycling accelerates both aggregation and oxidative degradation
This leads to feeling full longer and eating less throughout the day
Furthermore, they have the distinction of being the only BBB-accredited peptide company
[17] [18] The FDA issued a 2023 safety communication advising against probiotic use in preterm infants due to risk of invasive disease